APA (7th ed.) Citation

JF, F., N, C., & G, K. (2023). Extended-interval dosing of natalizumab in NOVA - Authors' reply. The Lancet. Neurology, 22(3), 200. https://doi.org/10.1016/S1474-4422(23)00034-0

Chicago Style (17th ed.) Citation

JF, Foley, Campbell N, and Kong G. "Extended-interval Dosing of Natalizumab in NOVA - Authors' Reply." The Lancet. Neurology 22, no. 3 (2023): 200. https://doi.org/10.1016/S1474-4422(23)00034-0.

MLA (9th ed.) Citation

JF, Foley, et al. "Extended-interval Dosing of Natalizumab in NOVA - Authors' Reply." The Lancet. Neurology, vol. 22, no. 3, 2023, p. 200, https://doi.org/10.1016/S1474-4422(23)00034-0.